VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Germline von Hippel-Lindau tumour suppressor gene (VHL) mutations cause renal cell carcinomas, haemangioblastomas and phaeochromocytomas in humans. Mutations in VHL also occur in sporadic renal cell carcinomas. The protein encoded by VHL, VHL, is part of the ubiquitin ligase that downregulates the heterodimeric transcription factor Hif under well-oxygenated conditions. Here we show that acute VHL inactivation causes a senescent-like phenotype in vitro and in vivo. This phenotype was independent of p53 and Hif but dependent on the retinoblastoma protein (Rb) and the SWI2/SNF2 chromatin remodeller p400. Rb activation occurred through a decrease in Skp2 messenger RNA, which resulted in the upregulation of p27 in a Hif-independent fashion. Our results suggest that senescence induced by VHL inactivation is a tumour-suppressive mechanism that must be overcome to develop VHL-associated neoplasias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One recent example supports this model: loss of function of the Von Hippel Lindau (VHL) tumour suppressor creates an oncogenic stress that triggers a senescence response both in vitro and in vivo.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
In the citing paper
“This senescent cell cycle arrest depends on the presence of functional RB128 and is in part mediated by the RB–SKP2 (S-phase kinase-associated protein 2)–p27 pathway.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
In the citing paper
“This senescent cell cycle arrest depends on the presence of functional RB128 and is in part mediated by the RB–SKP2 (S-phase kinase-associated protein 2)–p27 pathway.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [128]
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Hayashi, S., & McMahon, A. P. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0597 · Cited by 1,342
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
Telomerase maintains telomere structure in normal human cells
Kenichi, M., Yu, E. Y., Shilagardi, K., Ben‐Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Seishi, M., DeCaprio, J. A., et al. (2006) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 738
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611 · cited 1×
“To test this, we treated VHL fl/fl MEFs with vectors encoding constitutively active HIF-1α or HIF-2α point mutants that are not recognized by VH”
MethodSelf-citationHypoxia-Inducible Factor 1α Is Essential for Cell Cycle Arrest during Hypoxia
Goda, N., Ryan, H. E., Khadivi, B., McNulty, W., Rickert, R. C., & Johnson, R. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.359-369.2003 · Cited by 520
HIF activation identifies early lesions in VHL kidneys
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483
Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressor
Haase, V. H., Glickman, J. N., Socolovsky, M., & Jaenisch, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1583 · Cited by 424
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
Gardner, L. B., Li, Q., Park, M. S., Flanagan, W. M., Semenza, G. L., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010189200 · Cited by 390
Kaelin, W. G. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092049 · Cited by 336
Self-citationThe p400 Complex Is an Essential E1A Transformation Target
Fuchs, M., Gerber, J., Drapkin, R., Sif, S., Ikura, T., Ogryzko, V., Lane, W. S., Nakatani, Y., & Livingston, D. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00450-0 · Cited by 332
Wang, H. G., Rikitake, Y., Carter, M. C., Yaciuk, P., Abraham, S. E., Zerler, B., & Moran, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.476-488.1993 · Cited by 254
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601300 · Cited by 235 · cited 1×
“To test this, we treated VHL fl/fl MEFs with vectors encoding constitutively active HIF-1α or HIF-2α point mutants that are not recognized by VH”
MethodSelf-citationWalther, M. M., Lubensky, I. A., Venzon, D., Zbar, B., & Linehan, W. M. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)66674-6 · Cited by 187
King, F. W. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6297 · Cited by 167
HIF1α delays premature senescence through the activation of MIF
Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Broome Powell, M., & Giaccia, A. J. (2006) · Genes & Development · doi:10.1101/gad.1471106 · Cited by 163
The p400 E1A-associated protein is a novel component of the p53 → p21 senescence pathway
Chan, H. M., Narita, M., Lowe, S. W., & Livingston, D. M. (2005) · Genes & Development · doi:10.1101/gad.1280205 · Cited by 144
Li, L., Zhang, L., Zhang, X., Yan, Q., Minamishima, Y. A., Olumi, A. F., Mao, M., Bartz, S., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00282-07 · Cited by 110
Self-citationSamuelson, A. V., & Lowe, S. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12094 · Cited by 102
The thorny path linking cellular senescence to organismal aging
Patil, C. K., Mian, S. I., & Campisi, J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.08.001 · Cited by 83
Tissue-specific inactivation of p53 tumor suppression in the mouse.
Bowman, T., Symonds, H., Gu, L., Yin, C., Oren, M., & Van Dyke, T. (1996) · Genes & Development · doi:10.1101/gad.10.7.826 · Cited by 82
Mack, F. A., Patel, J. H., Biju, M. P., Haase, V. H., & Simon, M. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4565-4578.2005 · Cited by 74
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70 · cited 1×
“The ARNT shRNA retrovirus was made by using the pMKO vector as backbon”
MethodKip1 meets SKP2: new links in cell-cycle control
Amati, B. B., & Vlach, J. (1999) · Nature Cell Biology · doi:10.1038/12087 · Cited by 64
p400 Is Required for E1A to Promote Apoptosis
Samuelson, A. V., Narita, M., Chan, H.-M., Jin, J., de Stanchina, E., McCurrach, M. E., Narita, M., Fuchs, M., Livingston, D. M., & Lowe, S. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414564200 · Cited by 59
Ray, S. K., Nishitani, J., Petry, M. W., Fessing, M. Y., & Leiter, A. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.259-271.2003 · Cited by 48
Research works printed but not linked: 1
- Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244, 305–318 (2002). · DOI · Paper page
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Studies in murine models clarified that von Hippel–Lindau inactivation induced cellular senescence and benign renal tumors through the upregulation of pRB and p27 in a process dependent on functional p53 and HIF (361).”
BackgroundSystematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124
Metadata
- Authors
- Young, A. P., Schlisio, S., Minamishima, Y. A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Nature Cell Biology
- Published
- 2008-02-24
- Volume
- 10
- Issue
- 3
- Pages
- 361-369
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2158435332
- Cited by
- 239
- References
- 33
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 17 · 2019: 13 · 2018: 6 · 2017: 7 · 2016: 18 · 2015: 18 · 2014: 20 · 2013: 19 · 2012: 18
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- von Hippel-Lindau protein, VHL loss, cellular senescence, retinoblastoma protein, P400, Skp2, p27, tumor suppression, renal cell carcinoma, ubiquitin ligase
- MeSH terms
- Animals, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Membrane Glycoproteins, Mice, Transgenic, Mutation, Oxygen, Phenotype, Retroviridae, Calcium Channels, Retinoblastoma Protein, Cellular Senescence, Receptors, Cytoplasmic and Nuclear, Mice, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Inositol 1,4,5-Trisphosphate Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.